| |
|
|
|
Evofem Biosciences Inc  
|
|
2.515 -0.125 (-0.05%) |
10-21 14:24 |
|
Open: |
2.62 |
Pre close: |
2.64 |
Target:
|
3.48
|
|
High: |
2.6248 |
Low: |
2.45 |
Resistance:
|
2.98
3.48
|
|
Volume: |
1,371,621 |
Market Cap: |
204M |
Support:
|
2.32
1.91
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.74
 |
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
2.63  |
Signal(12,26,9): |
0.01 |
|
MA(100): |
2.92 |
Stochastic Oscillator |
%K(14,3):
|
55.12 |
|
MA(250): |
4.44 |
%D(3): |
70.56 |
|
Average Volume(K) |
3-Month: |
483271
|
52-Week |
High:
|
7.50 |
|
10-Days: |
217587 |
Low: |
1.91 |
|
RSI |
RSI(14):
|
41.92 |
Change(%): |
-49.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.938 |
Return on Equity (ttm) |
-188.5 |
Shares Out. (M) |
81.28 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-45.4 |
Shares Float (M) |
80.12 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
30.97 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
75.27 |
|
Forward EPS |
-1.990 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
13060 |
|
Book Value (p.s.) |
0.840 |
EBITDA (p.s.) |
-0.843 |
P/E |
-1.29 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.98 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-57.80 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-32.89 |
P/CF |
-3.52 |
|
|
|
|
|
|
